サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1435057

アルブミン＆クレアチニン検査市場：製品タイプ別、エンドユーザー別-2024-2030年の世界予測

Albumin & Creatinine Tests Market by Product (Analyzers, Cartridges, Dipsticks & Kits), Type (Blood & Serum Creatinine Tests, Urine Tests), End User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 186 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
アルブミン＆クレアチニン検査市場：製品タイプ別、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アルブミン＆クレアチニン検査市場規模は2023年に14億7,000万米ドルと推計され、2024年には16億6,000万米ドルに達し、CAGR 13.23%で2030年には35億2,000万米ドルに達すると予測されます。

アルブミン＆クレアチニン検査の世界市場

主な市場の統計
基準年[2023］ 14億7,000万米ドル
予測年[2024］ 16億6,000万米ドル
予測年 [2030] 35億2,000万米ドル
CAGR（%） 13.23%
Albumin &Creatinine Tests Market-IMG1

アルブミン＆クレアチニン検査市場は、血液または尿サンプル中のアルブミンおよびクレアチニン濃度を測定するために使用される診断機器、試薬、サービスを構成します。これらの検査は、腎機能の評価、慢性腎臓病（CKD）の検出、糖尿病性腎症の診断、さまざまな腎疾患の治療反応のモニタリングにおいて極めて重要です。糖尿病と高血圧の有病率の上昇、予防医療対策と早期診断に関する意識の高まり、バイオテクノロジーと生化学分析技術の進歩による検査精度の向上、迅速な結果が市場拡大の原動力となっています。さらに、利用しやすい検査オプションを必要とする人口が多い新興経済諸国は、政府がヘルスケア・インフラ整備により多くの資源を投資しているため、潜在的なビジネスチャンスをもたらしています。この分野には多くの成長の可能性があるにもかかわらず、検査手順の一貫性など特定の制限があるため、検査結果が不正確になり、患者管理に関する臨床的意思決定プロセスの妨げになる可能性があります。さらに、各国の医療保険政策に関連する償還の問題は、患者が高度な検査技術を利用することを制限しています。アルブミン＆クレアチニン検査市場における革新的な研究開発イニシアチブは、ビジネス成長の新たな機会を生み出すと予想されます。

地域別インサイト

南北アメリカ地域は、医療インフラが確立され、メーカーやプロバイダーに対する規制が厳しく、市場が成熟している地域です。米国やカナダで事業を展開するメーカーやプロバイダーは、FDAやカナダ保健省などの厳しい規制ガイドラインに直面しています。欧州連合（EU）では、ドイツ、フランス、イタリア、英国などの国々が、腎臓病に対する意識の高まりとヘルスケア・インフラの成長によってアルブミン＆クレアチニン検査の需要が増加しており、これが同地域の市場成長を牽引しています。APAC地域では、中国、日本、インドが急速な経済成長を遂げており、それに伴い医療施設も改善され、より優れた診断ツールへの需要が高まっています。慢性腎臓病（CKD）、糖尿病、高血圧の有病率の上昇、疾患の早期発見とモニタリングに対する意識の高まりが、同地域におけるアルブミン＆クレアチニン検査市場の需要を大幅に押し上げています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはアルブミン＆クレアチニン検査市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、アルブミン＆クレアチニン検査市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-アルブミン＆クレアチニン検査市場の市場規模および予測は？

2-アルブミン＆クレアチニン検査市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-アルブミン＆クレアチニン検査市場における技術動向と規制の枠組みは？

4-アルブミン＆クレアチニン検査市場における主要ベンダーの市場シェアは？

5-アルブミン＆クレアチニン検査市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性腎臓病の発生率の増加
      • ポイントオブケア（POC）診断の採用の増加
      • 尿路感染症の増加
    • 抑制要因
      • スポット尿採取と検査の問題
    • 機会
      • 全体的な尿分析のための自動システムの出現
      • 在宅検査キットのイントロダクションと病理検査室の急増
    • 課題
      • 農村部の精度と限られたインフラストラクチャへの懸念
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 アルブミン＆クレアチニン検査市場：製品別

  • アナライザー
  • カートリッジ
    • POC分析カートリッジ
    • 卓上分析カートリッジ
  • ディップスティックとキット
  • 試薬

第7章 アルブミン＆クレアチニン検査市場：タイプ別

  • 血液および血清クレアチニン検査
  • 尿検査
    • 糖化アルブミン検査
    • 尿中アルブミン検査
    • 尿中クレアチニン検査

第8章 アルブミン＆クレアチニン検査市場：エンドユーザー別

  • 診断研究所
  • 病院とクリニック
  • 調査および研究所

第9章 南北アメリカのアルブミン＆クレアチニン検査市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域のアルブミン＆クレアチニン検査市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカのアルブミン＆クレアチニン検査市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析
    • 契約、コラボレーション、パートナーシップ
    • 新製品発売と機能強化
    • 投資、資金調達

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abbott Laboratories
    • Abcam PLC
    • Anamol Laboratories Pvt. Ltd.
    • Arbor Assays Inc.
    • ARKRAY, Inc.
    • BTNX Inc.
    • CompareNetworks, Inc.
    • Danaher Corporation
    • Eagle Biosciences, Inc.
    • F. Hoffmann-La Roche AG
    • J. Mitra & Co. Pvt. Ltd.
    • Laboratory Corporation of America Holdings
    • Merck KGaA
    • Ortho Clinical Diagnostics
    • Practo Technologies Private Limited
    • PromoCell GmbH
    • Randox Laboratories Ltd.
    • Siemens AG
    • Sysmex Europe SE
    • Thermo Fisher Scientific Inc.
    • UJIFILM Wako Pure Chemical Corporation
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ALBUMIN & CREATININE TESTS MARKET RESEARCH PROCESS
  • FIGURE 2. ALBUMIN & CREATININE TESTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ALBUMIN & CREATININE TESTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ALBUMIN & CREATININE TESTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ALBUMIN & CREATININE TESTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ALBUMIN & CREATININE TESTS MARKET DYNAMICS
  • FIGURE 7. ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ALBUMIN & CREATININE TESTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ALBUMIN & CREATININE TESTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ALBUMIN & CREATININE TESTS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. ALBUMIN & CREATININE TESTS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ALBUMIN & CREATININE TESTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ALBUMIN & CREATININE TESTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALBUMIN & CREATININE TESTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. ALBUMIN & CREATININE TESTS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 9. ALBUMIN & CREATININE TESTS MARKET SIZE, BY POC ANALYZER CARTRIDGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ALBUMIN & CREATININE TESTS MARKET SIZE, BY TABLE-TOP ANALYZER CARTRIDGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ALBUMIN & CREATININE TESTS MARKET SIZE, BY DIPSTICKS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ALBUMIN & CREATININE TESTS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. ALBUMIN & CREATININE TESTS MARKET SIZE, BY BLOOD & SERUM CREATININE TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 17. ALBUMIN & CREATININE TESTS MARKET SIZE, BY GLYCATED ALBUMIN TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE ALBUMIN TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE CREATININE TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. ALBUMIN & CREATININE TESTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. ALBUMIN & CREATININE TESTS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ALBUMIN & CREATININE TESTS MARKET SIZE, BY RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ALBUMIN & CREATININE TESTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ALBUMIN & CREATININE TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM ALBUMIN & CREATININE TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM ALBUMIN & CREATININE TESTS MARKET SIZE, BY CARTRIDGES, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM ALBUMIN & CREATININE TESTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM ALBUMIN & CREATININE TESTS MARKET SIZE, BY URINE TESTS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM ALBUMIN & CREATININE TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. ALBUMIN & CREATININE TESTS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 234. ALBUMIN & CREATININE TESTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. ALBUMIN & CREATININE TESTS MARKET LICENSE & PRICING
目次
Product Code: MRR-BD7616820FA3

[186 Pages Report] The Albumin & Creatinine Tests Market size was estimated at USD 1.47 billion in 2023 and expected to reach USD 1.66 billion in 2024, at a CAGR 13.23% to reach USD 3.52 billion by 2030.

Global Albumin & Creatinine Tests Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.47 billion
Estimated Year [2024] USD 1.66 billion
Forecast Year [2030] USD 3.52 billion
CAGR (%) 13.23%
Albumin & Creatinine Tests Market - IMG1

The albumin & creatinine tests market constitutes diagnostic devices, reagents, and services used to measure albumin and creatinine levels in blood or urine samples. These tests are crucial in evaluating kidney function, detecting chronic kidney disease (CKD), diagnosing diabetic nephropathy, and monitoring treatment responses for various renal conditions. The rising prevalence of diabetes mellitus and hypertension, increased awareness regarding preventive healthcare measures and early diagnosis, advancements in biotechnology and biochemical analysis techniques improving test accuracy, and faster results drive market expansion. Additionally, emerging economies with large populations requiring accessible testing options present potential opportunities as governments invest more resources into healthcare infrastructure development. Despite the numerous growth avenues within this sector, certain limitations, including consistency in testing procedures, may lead to inaccuracies in test results hindering clinical decision-making processes concerning patient management. Furthermore, reimbursement issues related to medical insurance policies across countries limit patients' access to advanced testing technologies. Innovative research and development initiatives within the albumin & creatinine tests market are anticipated to generate new opportunities for business growth.

Regional Insights

The Americas region represents a mature landscape for the market, with established medical infrastructures and stringent regulations governing manufacturers and providers. Manufacturers and providers operating in the U.S., and Canada, face strict regulatory guidelines from agencies such as FDA and Health Canada to commercialize the products in the market. In the European Union, countries such as Germany, France, and Italy, along with the UK, have seen increasing demand for albumin & creatinine tests due to rising awareness about kidney diseases coupled with growth in healthcare infrastructure which is driving the market growth in the region. In the APAC region, China, Japan, and India are experiencing rapid economic growth accompanied by improving healthcare facilities that drive demand for better diagnostic tools. The rising prevalence of chronic kidney diseases (CKD), diabetes, and hypertension, as well as increased awareness about early disease detection and monitoring, has significantly boosted the demand for the albumin & creatinine tests market in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Albumin & Creatinine Tests Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Albumin & Creatinine Tests Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Albumin & Creatinine Tests Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, Anamol Laboratories Pvt. Ltd., Arbor Assays Inc., ARKRAY, Inc., BTNX Inc., CompareNetworks, Inc., Danaher Corporation, Eagle Biosciences, Inc., F. Hoffmann-La Roche AG, J. Mitra & Co. Pvt. Ltd., Laboratory Corporation of America Holdings, Merck KGaA, Ortho Clinical Diagnostics, Practo Technologies Private Limited, PromoCell GmbH, Randox Laboratories Ltd., Siemens AG, Sysmex Europe SE, Thermo Fisher Scientific Inc., and UJIFILM Wako Pure Chemical Corporation.

Market Segmentation & Coverage

This research report categorizes the Albumin & Creatinine Tests Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Analyzers
    • Cartridges
      • POC Analyzer Cartridges
      • Table-top Analyzer Cartridges
    • Dipsticks & Kits
    • Reagents
  • Type
    • Blood & Serum Creatinine Tests
    • Urine Tests
      • Glycated Albumin Tests
      • Urine Albumin Tests
      • Urine Creatinine Tests
  • End User
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Research Laboratories & Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Albumin & Creatinine Tests Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Albumin & Creatinine Tests Market?

3. What are the technology trends and regulatory frameworks in the Albumin & Creatinine Tests Market?

4. What is the market share of the leading vendors in the Albumin & Creatinine Tests Market?

5. Which modes and strategic moves are suitable for entering the Albumin & Creatinine Tests Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Albumin & Creatinine Tests Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of chronic kidney disorders
      • 5.1.1.2. Rising adoption of point-of-care (POC) diagnostics
      • 5.1.1.3. Growing cases of urinary tract infections
    • 5.1.2. Restraints
      • 5.1.2.1. Problems with spot urine sampling and testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of automated systems for overall urine analysis
      • 5.1.3.2. Introduction of home testing kit coupled with surge in number of pathology laboratory
    • 5.1.4. Challenges
      • 5.1.4.1. Concern with the accuracy and limited infrastructure in rural areas
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Albumin & Creatinine Tests Market, by Product

  • 6.1. Introduction
  • 6.2. Analyzers
  • 6.3. Cartridges
    • 6.4.1. POC Analyzer Cartridges
    • 6.4.2. Table-top Analyzer Cartridges
  • 6.4. Dipsticks & Kits
  • 6.5. Reagents

7. Albumin & Creatinine Tests Market, by Type

  • 7.1. Introduction
  • 7.2. Blood & Serum Creatinine Tests
  • 7.3. Urine Tests
    • 7.4.1. Glycated Albumin Tests
    • 7.4.2. Urine Albumin Tests
    • 7.4.3. Urine Creatinine Tests

8. Albumin & Creatinine Tests Market, by End User

  • 8.1. Introduction
  • 8.2. Diagnostic Laboratories
  • 8.3. Hospitals & Clinics
  • 8.4. Research Laboratories & Institutes

9. Americas Albumin & Creatinine Tests Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Albumin & Creatinine Tests Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Albumin & Creatinine Tests Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player
    • 12.3.1. Agreement, Collaboration, & Partnership
      • 12.3.1.1. Healthy.io Announces Collaboration with Boehringer Ingelheim to Increase Access to Testing for Kidney Disease
    • 12.3.2. New Product Launch & Enhancement
      • 12.3.2.1. American Regent Launches Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)
    • 12.3.3. Investment & Funding
      • 12.3.3.1. Healthy.io Secures USD 50 Million in Series D Funding

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Abbott Laboratories
    • 13.1.2. Abcam PLC
    • 13.1.3. Anamol Laboratories Pvt. Ltd.
    • 13.1.4. Arbor Assays Inc.
    • 13.1.5. ARKRAY, Inc.
    • 13.1.6. BTNX Inc.
    • 13.1.7. CompareNetworks, Inc.
    • 13.1.8. Danaher Corporation
    • 13.1.9. Eagle Biosciences, Inc.
    • 13.1.10. F. Hoffmann-La Roche AG
    • 13.1.11. J. Mitra & Co. Pvt. Ltd.
    • 13.1.12. Laboratory Corporation of America Holdings
    • 13.1.13. Merck KGaA
    • 13.1.14. Ortho Clinical Diagnostics
    • 13.1.15. Practo Technologies Private Limited
    • 13.1.16. PromoCell GmbH
    • 13.1.17. Randox Laboratories Ltd.
    • 13.1.18. Siemens AG
    • 13.1.19. Sysmex Europe SE
    • 13.1.20. Thermo Fisher Scientific Inc.
    • 13.1.21. UJIFILM Wako Pure Chemical Corporation
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing